|
Title
|
|
|
|
Questions regarding the randomized phase II trial of defactinib as maintenance therapy in malignant pleural mesothelioma : reply
|
|
|
Author
|
|
|
|
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Journal of clinical oncology. - New York
|
|
|
Publication
|
|
|
|
Alexandria
:
Amer soc clinical oncology
,
2019
|
|
|
ISSN
|
|
|
|
0732-183X
|
|
|
DOI
|
|
|
|
10.1200/JCO.19.01208
|
|
|
Volume/pages
|
|
|
|
37
:25
(2019)
, p. 2294-2295
|
|
|
ISI
|
|
|
|
000484486200015
|
|
|
Pubmed ID
|
|
|
|
31329517
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|